Nature's Miracle Holding Inc. NMHI
0.00
0.00
NaN
as of 25 Sep
- Market cap
- $1.1M
- P/E
- 0.0×
Follow NMHI
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.00 | 0.94 | 0.65 | 0.08 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
0.00 | (0.75) | (1.63) | (1.32) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
15.59 | 5.98 | 4.52 | 1.19 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.11) | (2.61) | (2.24) | (1.23) | |
EV/FCF |
(1.77) | (2.60) | (2.24) | (1.23) | |
Quick Ratio |
0.02 | 0.01 | 0.08 | 0.10 | |
Current Ratio |
0.07 | 0.04 | 0.14 | 0.14 | |
Net Debt/EBITDA |
(16.54) | (3.31) | (8.67) | (5.97) | |
Debt/Assets |
49.25% | 43.45% | 38.32% | 64.61% | |
Debt/Equity |
(1.14) | (0.70) | (0.94) | (0.34) | |
Asset Turnover |
0.04 | 0.11 | 0.12 | 0.47 | |
Operating CF/Net income |
(0.56) | 0.36 | 0.41 | 0.18 | |
Capex/Depreciation |
(2.22) | 0.00 | 0.08 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2,619.71% | 1,690.91% | 1,664.64% | 211.90% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
251.92% | 140.78% | 116.16% | 12.60% | |
Graham Net Nets |
0.00 | (19.61) | (19.91) | (55.82) | |
Graham Number |
0.66 | 3.88 | 9.73 | 22.08 | |
Earnings Yield |
0.00% | (712.91%) | (3,897.15%) | (10,827.14%) | |
Free Cash Flow Yield |
0.00% | (244.33%) | (312.06%) | (1,228.15%) | |
Revenue per Share |
0.00 | 0.01 | 0.01 | 0.08 | |
Operating CF per Share |
(0.01) | (0.15) | (0.08) | (0.05) | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.02) | (0.15) | (0.08) | (0.05) | |
Cash per Share |
0.00 | 0.01 | 0.01 | 0.00 | |
Shareholders Equity per Share |
(0.06) | (0.85) | (0.83) | (2.86) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.06) | (0.85) | (0.83) | (2.86) | |
Free Cash Flow |
(2.61) | (2.18) | (0.87) | (0.31) | |
Working Capital |
(17.62) | (22.30) | (19.75) | (17.52) | |
Capital Expenditures |
(1.00) | 0.00 | 0.03 | — | |
Net Current Asset Value |
(29.52) | (32.20) | (29.15) | (23.19) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
24.04 | 0.00 | (0.36) | 0.00 | |
Net Profit Margin |
6,839.66% | (7,561.74%) | (3,048.07%) | (365.89%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.42 | 1.48 | 2.98 | 2.40 | |
Average Payables |
6.82 | 10.37 | 9.81 | 10.62 | |
Average Inventory |
— | — | 1.99 | 2.44 | |
Average Assets |
15.68 | 15.86 | 18.45 | 11.15 | |
Average Common Equity |
(12.33) | (13.54) | (10.60) | (15.05) |
Columns are period end dates